DOI:
10.1055/s-00000173
Neuroradiologie Scan
LinksClose Window
References
Lublin F, Miller DH, Freedman MS. et al.
Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial.
Lancet 2016;
387: 1075-1084
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.